Global Colorectal Cancer (CRC) Diagnostics and Treatments Market Comprehensive Analysis and Forecast 2025 to 2030
Global Colorectal Cancer (CRC)
Diagnostics and Treatments Market Overview: 2025-2030
Base Year: 2024
Historical Years:
2020-23
Forecast Years: 2025-2030
The Global
Colorectal Cancer (CRC) Diagnostics and Treatments Market size was valued at
around USD10.89 Billion in 2024 and is projected to reach USD16.89 Billion by
2030. Along with this, the market is estimated to grow at a CAGR of around 7.6%
during the forecast period, i.e., 2025-30. The Global Colorectal
Cancer (CRC) Diagnostics and Treatments Market is going through
significant growth due to multiple drivers like technological advancements and,
of course, increasing healthcare needs. The increase in road accidents
throughout the country creates a greater demand for X-rays.
Markntel
Advisor’s Global Colorectal Cancer (CRC)
Diagnostics and Treatments Market Insights report provides the current and
forecast market analysis, individual leading companies' market shares,
challenges, Global Colorectal Cancer (CRC) Diagnostics and Treatments Market
drivers, barriers, Global Colorectal Cancer (CRC) Diagnostics and Treatments
Market Trends, and Key Players in Global Colorectal Cancer (CRC) Diagnostics
and Treatments Market.
Download
a sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/colorectal-cancer-crc-market.html
Global Colorectal Cancer (CRC)
Diagnostics and Treatments Market Dynamics: 2025-2030
Global Colorectal Cancer (CRC)
Diagnostics and Treatments Market Driver:
High Ubiquity of Colorectal Cancer
Driving Demand –
Globally, colorectal cancer is a major health concern. 930,000 people died and
10. 9 million new cases were reported worldwide in 2020. The number of cases is
expected to increase to 32. 2 million by 2040, with 12. 6 million expected
deaths. The disease is most common in countries with high or extremely high
HDI. With 10% of cases worldwide, it is the second most common cause of
cancer-related deaths and the third most common type of cancer overall.
Different geographic prevalence rates indicate that colorectal cancer (CRC) is
most common in Australia, New Zealand, and Europe, while it is less common in
some parts of Africa and Southern Asia.
These geographic
disparities underscore the necessity for regional strategies in CRC management.
In light of the increasing incidence of CRC, novel diagnostic technologies are
being created. A recent innovation involves a small robot that can travel
through the digestive tract and conduct 3D scans to facilitate improved early
detection and treatment. The high incidence will drive the market growth
throughout the forecast period and beyond.
Browse
Full Report with Detail Analysis –
https://www.marknteladvisors.com/research-library/colorectal-cancer-crc-market.html
Global Colorectal Cancer (CRC)
Diagnostics and Treatments Market (2025-30): Segmentation Outlook
The market
report has segmented the market into the following categories:
By Diagnosis
-Blood &
Stool Tests
-Imaging
-Biopsy
-Flexible
Sigmoidoscopy
-Colonoscopy
By Treatment
-Chemotherapy
-Alkylating
Agents
-Antimetabolites
-Fluorouracil
-Capecitabine
-Others
-Immunotherapy
-Monoclonal
Antibodies
-Bevacizumab
-Cetuximab
-Panitumumab
-Biologic
Response Modifiers
-Colony-Stimulating
Factors
-Tumor Vaccines
-Surgery
-Targeted
Therapy
-Others
(Radiofrequency Ablation (RFA), etc.)
By End-User
-Hospitals
-Specialty
Clinics
-Others
(Ambulatory Surgery Centers, etc.)
By Region
-North America
-South America
-Europe
-Middle East
& Africa
-Asia-Pacific.
Note - If there are any particular
details you need that are not currently included in the report, we will be
happy to provide them as part of our customization
services.
Top Companies Operating in the Global
Colorectal Cancer (CRC) Diagnostics and Treatments Market:
Abbott
Laboratories, Amgen Inc., Bayer AG, Bristol Myers Squibb, Eli Lilly and
Company, GlaxoSmithKline PLC, F. Hoffmann-La Roche AG, Merck & Co., Inc.,
Novartis International AG, Pfizer Inc.
Reports Delivery
Format - Market research studies from MarkNtel Advisors are offered in PDF,
Excel, and PowerPoint formats. Within 24 hours of the payment being
successfully received, the report will be sent to your email address
About Us –
We are a leading
market research company, consulting, & data analytics firm that provides an
extensive range of strategic reports on diverse industry verticals. We deliver
data to a substantial & varied client base, including multinational
corporations, financial institutions, governments, & individuals, among
others.
Our specialization
in niche industries & emerging geographies allows our clients to formulate
their strategies in a much more informed way and entail parameters like
Go-to-Market (GTM), product development, feasibility analysis, project scoping,
market segmentation, competitive benchmarking, market sizing & forecasting,
& trend analysis, among others, for 15 diverse industrial verticals.
Contact Us –
Email: sales@marknteladvisors.com
Sales Office:
564 Prospect St, B9, New Haven, Connecticut, USA-06511
Address
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301,
India
Comments
Post a Comment